Literature DB >> 17483685

Wegener's granulomatosis: current trends in diagnosis and management.

Vanessa R Erickson1, Peter H Hwang.   

Abstract

PURPOSE OF REVIEW: To provide an update on diagnostic methods and treatment options for Wegener's granulomatosis and to review common head and neck manifestations of the disease. RECENT
FINDINGS: Recent advances have been made in the systemic treatment of Wegener's granulomatosis, including the introduction of investigational immunosuppressive agents such as etanercept, leflunomide and deoxyspergualin. Surgical options remain indicated in selected complications of Wegener's granulomatosis such as saddle nose deformity and subglottic stenosis.
SUMMARY: Wegener's granulomatosis is an idiopathic, systemic vasculitis characterized by the formation of necrotizing granulomas of the respiratory tract in addition to focal or proliferative glomerulonephritis. Diagnosis is made by a combination of physical examination, laboratory studies and tissue biopsy. Head and neck manifestations are abundant and varied; common sites of involvement include the middle ear, nose and sinuses and subglottis. The mainstay of treatment remains systemic therapy using a combination of glucocorticoids and immunosuppressants. The otolaryngologist plays a key role in the diagnosis and treatment of head and neck complications of the disease. A surgical role exists for the management of nasal and sinus disease as well as laryngeal and tracheal disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483685     DOI: 10.1097/MOO.0b013e3281568b96

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  21 in total

1.  Case 2: A teenage boy with epistaxis.

Authors:  Amy E French; Susanne M Benseler; Catherine S Birken
Journal:  Paediatr Child Health       Date:  2009-02       Impact factor: 2.253

2.  Evaluation of smell and taste in patients with Wegener's granulomatosis.

Authors:  James A Fasunla; Walter Hundt; Jens Lutz; Frauke Förger; Klaus Thürmel; Silke Steinbach
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-12       Impact factor: 2.503

3.  Clinical pathologic conference case 1: Wegener's granulomatosis.

Authors:  Susan Müller; Siema Eljack; John M DelGaudio
Journal:  Head Neck Pathol       Date:  2011-08-23

4.  Orbital apex syndrome secondary to granulomatosis with polyangiitis.

Authors:  Sarah Siddiqui; Andrew Jon Kinshuck; Venkat Ramanan Srinivasan
Journal:  BMJ Case Rep       Date:  2013-12-05

5.  Autoimmune dysfunction and subsequent renal insufficiency in a collegiate female athlete: a case report.

Authors:  James E Leone; Amie Kern; Joshua D Williamson; Robert M Colandreo
Journal:  J Athl Train       Date:  2010 Nov-Dec       Impact factor: 2.860

6.  [Pulmonary emergencies in connective tissues disorders and vasculitides].

Authors:  J O Schröder; R A Zeuner; B Bewig; M Both
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

7.  A contemporary analysis of clinical and demographic factors of chronic rhinosinusitis patients and their association with disease severity.

Authors:  L P Hoehle; K M Phillips; D S Caradonna; S T Gray; A R Sedaghat
Journal:  Ir J Med Sci       Date:  2017-05-30       Impact factor: 1.568

8.  Priority-setting tools for rheumatology disease referrals: a review of the literature.

Authors:  Carolyn De Coster; Avril Fitzgerald; Monica Cepoiu
Journal:  Clin Rheumatol       Date:  2008-06-17       Impact factor: 2.980

9.  Polyamine compound deoxyspergualin inhibits heat shock protein-induced activation of immature dendritic cells.

Authors:  Atsushi Sugawara; Toshihiko Torigoe; Yasuaki Tamura; Kenjiro Kamiguchi; Kyuichi Nemoto; Hiroshi Oguro; Noriyuki Sato
Journal:  Cell Stress Chaperones       Date:  2008-08-07       Impact factor: 3.667

10.  Successful endonasal dacryocystorhinostomy in a patient with Wegener's granulomatosis.

Authors:  P Eloy; E Leruth; B Bertrand; P H Rombaux
Journal:  Clin Ophthalmol       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.